GLP-1 Education.
Independent Provider Review.
Clear Evidence Boundaries.
GLP-1 is one of the body's incretin hormones. Medications such as semaglutide and tirzepatide act on GLP-1-related pathways and have approved uses with specific eligibility, dosing, safety, and monitoring requirements. FormBlends provides education and can connect eligible users with independent licensed providers who make prescribing decisions.
What We Actually Do
FormBlends is a platform that provides education, collects intake information, and can route eligible users to independent licensed provider review. FormBlends is not a medical practice and does not make prescribing decisions. If a provider issues a prescription, fulfillment depends on the medication, patient, state, and pharmacy pathway.
A 503A pharmacy generally compounds patient-specific prescriptions under state-board oversight and applicable federal and state rules. A 503B outsourcing facility follows a different federal pathway. Compounded medications are not FDA-approved finished products, and availability or legal permissibility should not be inferred from a general article; the actual prescription and dispensing pathway matter.
Our content distinguishes evidence for FDA-approved branded products from evidence for compounded formulations and investigational compounds. Trial outcomes should not be presented as guaranteed personal results or automatic proof that a compounded formulation is equivalent to a branded drug.
Real Pharmacy Sourcing
When pharmacy fulfillment applies, the order should identify the dispensing pathway and the quality documentation available for that specific medication and lot.
Independent Provider Review
A licensed provider reviews the health history and decides whether treatment is appropriate. FormBlends does not prescribe medications or override clinical judgment.
Evidence Status Made Visible
Approved, compounded, and investigational options do not share the same evidence or regulatory status. Our content should state those differences clearly.
Responsive Support
Questions about your order, dosing schedule, or next steps? Our support team targets a 2-hour response time during business hours.
Source review and independent clinical decisions
FormBlends editorial pages use source review unless a named clinician is explicitly shown. Independent licensed providers make patient-specific prescribing decisions; that provider review is separate from article review.
FormBlends Editorial Standards Team
We do not claim a clinician reviewed an article unless the named reviewer, credentials, review scope, and review date can be verified. Until then, pages are labeled as editorially source reviewed against medical, regulatory, trial, and public-health references where available.
How responsibilities are divided
Editorial
FormBlends researches and explains
Provider
Licensed clinicians decide and prescribe
Pharmacy
The dispensing facility compounds or fills
Patient
Personal decisions require informed consent
How we separate education, provider review, and pharmacy quality
Health pages should make the next step clearer, not blur the line between general education and personal medical care. These pages explain the standards behind the FormBlends platform.
How FormBlends Works
The intake, provider review, pharmacy fulfillment, and follow-up path.
Provider Network
How independent licensed providers make prescribing decisions.
Medical Review Process
How clinical, regulatory, and safety claims are checked.
Source Standards
The evidence hierarchy for PubMed, FDA, public data, and lower-confidence sources.
Pharmacy and Quality
How we explain 503A, 503B, compounding limits, and quality documentation.
Editorial Policy
Corrections, conflicts, pricing checks, and update standards.
Ready to Get Started?
See if physician-supervised GLP-1 therapy is right for you. Browse our medications or start with a consultation.